Related Experiment Video

Updated: May 27, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Microbial transformation of 3,4-methylenedioxy-N-methylamphetamine and 3,4-methylenedioxyamphetamine

B C Foster, D L Wilson, T Marwood

    Canadian Journal of Microbiology
    |November 5, 2011
    PubMed

    Insights

    The fungus Cunninghamella echinulata biotransformed 3,4-methylenedioxy-N-methylamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA), producing novel acetylated metabolites like N-Acetyl-3,4-methylenedioxyamphetamine (NAcMDA). This study identifies new metabolic pathways for these amphetamines in a fungal model.

    Area of Science:

    • Microbial Biotransformation
    • Drug Metabolism
    • Mycology

    Background:

    • Understanding the metabolic fate of psychoactive substances like MDMA and MDA is crucial for pharmacology and toxicology.
    • Fungal models, such as Cunninghamella echinulata, offer a valuable alternative system for studying xenobiotic metabolism, complementing mammalian studies.

    Purpose of the Study:

    • To investigate the biotransformation pathways of 3,4-methylenedioxy-N-methylamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) using the fungus Cunninghamella echinulata.
    • To identify and characterize novel metabolites produced during fungal biotransformation of MDMA and MDA.

    Main Methods:

    • Incubation of MDMA and MDA with Cunninghamella echinulata cultures.
    • Analysis of culture extracts using chromatographic and spectroscopic techniques (e.g., HPLC, MS, NMR) to identify metabolites.
    • Comparison of fungal metabolites with known mammalian metabolites.

    Main Results:

    • Six novel metabolites were detected in addition to known mammalian metabolites and parent compounds.
    • N-Acetyl-3,4-methylenedioxyamphetamine (NAcMDA) was unequivocally identified as a metabolite of both MDMA and MDA.
    • Tentative identification of N-Acetyl-3,4-methylenedioxy-1-phenyl-1-hydroxy-2-aminopropane as an MDMA metabolite, along with other unidentified related compounds.

    Conclusions:

    • Cunninghamella echinulata effectively biotransforms MDMA and MDA, producing unique metabolites, including acetylated forms.
    • The identification of NAcMDA as a common metabolite highlights potential shared metabolic pathways.
    • This study expands the known metabolic profile of MDMA and MDA, providing insights into fungal metabolism of amphetamines.

    More Related Videos

    Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM2001611:04

    Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016

    Published on: June 23, 2023

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones06:06

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

    Published on: February 5, 2018

    Related Concept Videos

    Phase II Reactions: Methylation Reactions01:17

    Phase II Reactions: Methylation Reactions

    Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
    The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
    Transformation01:26

    Transformation

    Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
    Bacterial Transformation01:33

    Bacterial Transformation

    In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
    Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
    Carboxylic Acids to Methylesters: Alkylation using Diazomethane01:33

    Carboxylic Acids to Methylesters: Alkylation using Diazomethane

    Carboxylic acids react with diazomethane in an ether solvent via alkylation at the carboxylate oxygen atom to give methyl esters of the corresponding acid with excellent yields.
    Microbes and Methanogenesis01:26

    Microbes and Methanogenesis

    Methanogenesis is a critical microbial process in anaerobic ecosystems responsible for the biological production of methane, a potent greenhouse gas and valuable biofuel. This metabolic pathway is primarily facilitated by methanogenic archaea, which thrive in anoxic environments such as wetlands, sediments, and animal gastrointestinal tracts. The absence of oxygen in these habitats prevents aerobic respiration, thereby favoring alternative biochemical pathways for organic matter degradation.In...
    Drug Biotransformation: Overview01:16

    Drug Biotransformation: Overview

    Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...